Evaluation of CRP and D-dimer of Confirmed COVID-19 patients at a Tertiary Care Hospital, Correlation with Comorbidity
Md. Sumon Rahman
Modern Medical Center, Dhaka, Bangladesh
Md. Rashidul Islam
Bangladesh University of Health Sciences, Dhaka, Bangladesh
Sadia Moriom
Medical College for Women and Hospital, Dhaka, Bangladesh
Md. Shapan Ali Sheikh
Primeasia University, Dhaka, Bangladesh
Md. Rohomot Mostofa Rasel
Bangladesh University of Health Sciences, Dhaka, Bangladesh
Md. Al-Amin Hossen
United Hospital Limited, Dhaka, Bangladesh
DOI: https://doi.org/10.59429/mmr.v4i1.12217
Keywords: COVID-19; C-Reactive Protein; D-Dimer; Respiratory Manifestations; Comorbidity
Abstract
Since the COVID-19 outbreak started in 2019 in China, several types of research have been done on this disease But the outcome was not always satisfactory. As frequent changes occur in one’s genome, signs and symptoms of this disease vary in different variants. Many investigations have been employed for the detection of COVID-19 infection. Of these, D-dimer and CRP are used to evaluate the presence of systemic response against coronavirus insult. To evaluate whether CRP and D-d-imer levels are significantly higher in COVID-19 patients with respiratory manifestations compared to those with non-respiratory symptoms. 80 male patients were selected randomly, and divided into 2 groups; 40 patients presented with severe respiratory distress symptoms, and 40 presented with symptoms other than respiratory features (mostly gastric symptoms with high fever). CRP and D-dimer tests were done and data were used for subsequent statistical analysis. There was a significant difference in the level of both CRP and D-dimer between patients with dyspnea and those with no respiratory manifestation of COVID-19. In conclusion, a high level of both CRP and D-dimer is a highly suggestive respiratory insult and future complication of COVID-19.
References
1.Rahman T, Ahmed N, Islam B, Bhuiyan MM, Al Amin AM, Begum A, Al Faroque A, Biswas PS, Ghosh S. Association Between Serum C-Reactive Protein (CRP) And D-Dimer Levels In Covid-19 Patients In A Tertiary Level Hospital, Khulna. Journal of Dhaka Medical College. 2023;32(1):57-62.
2.El-Bolkiny YE, Eid MA. CRP, D-dimer, and Comorbidities as Potential Prognostic Factors in Critically Ill COVID-19 Patients. Egyptian Journal of Cancer and Biomedical Research. 2024 Mar 1;8(1):41-51.
3.Reza S, Abd Armina U, Shah MS, Begum M, Kabir AL, Afrin T, Chowdhury MR, Rajib MS, Dey S, Nesa Z. D-Dimer Level on Admission as an Outcome Predictor of COVID-19 Patients in Tertiary Care Hospitals in Bangladesh. Haematology Journal of Bangladesh. 2024 Dec 10;8(2):63-70.
4.Fatima KB, Salam MT, Biswash MA, Rana MS, Das SS, Hossian M, Bashir MS, Sikder NF, Shahin HR, Ali R, Uddin N. Assessing the predictive accuracy of IL-6, CRP, PCT, and D-Dimer for mortality in COVID-19 ICU patients. Journal of Primeasia. 2024 Jul 17;5(1):1-8.
5.Debi H, Itu ZT, Amin MT, Hussain F, Hossain MS. Association of serum C-reactive protein (CRP) and D-dimer concentration on the severity of COVID-19 cases with or without diabetes: a systematic review and meta-analysis. Expert Review of Endocrinology & Metabolism. 2022 Jan 2;17(1):83-93.
6.Jahagirdar P, Vaishnav K, Sarathy NA, Singh H, Kumia K, Banerjee A. Role of C-reactive protein, IL-6, and D-dimers in prediction of severity of coronavirus disease 2019: A pilot study. Journal of Oral and Maxillofacial Pathology. 2024 Apr 1;28(2):205-10.
7.Rana MS, Das SS, Hossian M, Bashir MS. Impact and challenges of digital marketing in health care during the COVID-19 pandemic. Journal of Primeasia. 2023 Oct 19;4(1):1-4.
8.Afrin SF, Rahman MH, Al Mahmood AK, Nasir S, Khatun S. Assessment of COVID severity by measuring D-dimer and Serum Ferritin level in selected Tertiary Care Hospitals of Dhaka city. Bangladesh Journal of Medical Science. 2021 Sep 5:166-70.
9.Mim F, Reza MS, Khalil MI, Karim N, Shahjalal HM, Hossain MI, Hossain MS. Assessment of serum electrolytes, biochemical, and inflammatory markers in predicting COVID-19 severity in COPD patients. COVID. 2023 May 24;3(6):792-806.
10.Ferdous K, Rahmanb MA, Islam S, Tasnim S, Ferdausi T, Rahaman S, Hossen MA, Rimu AJ. Complete Blood Count (CBC) in COVID-19 Patients Attending at Bangladesh Institute of Health Sciences (BIHS) General Hospital, Dhaka, Bangladesh. J. Appl. Life Sci. Int. 2023 Aug 30;26(5):27-34.
11.Hasan MZ, Biswas NK, Aziz AM, Chowdhury J, Haider SS, Sarker M. Clinical profile and short-term outcomes of RT-PCR-positive patients with COVID-19: a cross-sectional study in a tertiary care hospital in Dhaka, Bangladesh. BMJ open. 2021 Dec 1;11(12):e055126.
12.Mithun S, Abdullah SA, Irfan SN. Assessment of Biochemical Changes Among Covid-19 Cases in a Tertiary Hospital of Bangladesh During Early Pandemic. Journal of Preventive and Social Medicine. 2021;40(1):34-42.
13.Ullah W, Thalambedu N, Haq S, Saeed R, Khanal S, Tariq S, Roomi S, Madara J, Boigon M, Haas DC, Fischman DL. Predictability of CRP and D-Dimer levels for in-hospital outcomes and mortality of COVID-19. Journal of community hospital internal medicine perspectives. 2020 Sep 2;10(5):402-8.